InvestorsHub Logo
Followers 0
Posts 1588
Boards Moderated 0
Alias Born 07/27/2016

Re: Biotech Pharmer post# 11917

Wednesday, 10/18/2017 2:51:23 PM

Wednesday, October 18, 2017 2:51:23 PM

Post# of 20617
I think Q3 & Q4 will be the tell all as to whether or not management was pumping up on hype or not. They have made some claims regarding fees paid to handle their product. I don't know what those conditions were but Damage made some claim about Q3 being their best quarter in the past. If there is little increase in Revenue, Dr. Da has some explaining to do.

I still have not been convinced they know how to market their product based on search engine lack of results for INNV product. Other companies with less revs come up.

So not much longer for the Q3. I still feel revs will be between 2.1 & 2.4M which is unimpressive for the length of time INNV has had.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.